Market data loadingS&P 500--NASDAQ--Data as of latest ETNo timestamp

Alumis Inc. (ALMS) Cash Flow Statement

Alumis Inc. (ALMS) generated -$351.4M of operating cash flow over the twelve months to 2026-06-30, spent $401000 on capital expenditure and had free cash flow of -$351.8M, according to EquiReason's reading of its SEC filings.

Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason

ALMSAlumis Inc.Follow ALMS — free
Biotechnology · Healthcare
—
Price chart with a free account
Market cap
877.6M
P/E TTM
—
Dividend yield
—
52-week
—
Next earnings
12 Nov, in 19 days
LineFY2025
Dec 25
TTM
Jun 26
Trend
Operating cash flow-369.5-351.4
Capital expenditure0.7-0.4
Free cash flow-370.2-351.8
Share repurchases0.0—
Stock-based compensation43.5—

USD millions · SEC XBRL

Alumis Inc. — questions

What is Alumis Inc.'s operating cash flow?
-$351.4M over the twelve months to 2026-06-30.
How much does Alumis Inc. spend on capital expenditure?
$401000 over the twelve months to 2026-06-30.
What is Alumis Inc.'s free cash flow?
-$351.8M over the twelve months to 2026-06-30: operating cash flow minus capital expenditure.

Every figure on this page comes from Alumis Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.

How these figures are read: methodology · EquiReason.